Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Asterias Biotherapeutics, Inc./ EFFECT

SEC Filing · EFFECT

Asterias Biotherapeutics, Inc.

SEC Filing

Filed Mar 19, 2019Accepted Mar 19, 2019, 8:15 PM EDTCIK 1572552Accession 9999999995-19-000458
View company →Permanent SEC source ↗
Share

Company context

Historical securities (2)
AST.WSNYSE_AMERICAN · WARRANT · Historical · closed Sep 27, 2017AST.WSwNYSE_AMERICAN · WARRANT · Historical · closed Apr 26, 2016

Recent company filings

  1. 15-12B filingMar 20, 2019
  2. EFFECT filingMar 19, 2019
  3. EFFECT filingMar 19, 2019
  4. S-8 POS filingMar 14, 2019
  5. POS AM filingMar 14, 2019

As-filed source

Primary evidence
As filedOpen full document ↗